These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29243286)

  • 1. Conformational dynamics of human protein kinase CK2α and its effect on function and inhibition.
    Srivastava A; Hirota T; Irle S; Tama F
    Proteins; 2018 Mar; 86(3):344-353. PubMed ID: 29243286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design.
    Niefind K; Issinger OG
    Biochim Biophys Acta; 2010 Mar; 1804(3):484-92. PubMed ID: 19796713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density crystal packing of human protein kinase CK2 catalytic subunit in complex with resorufin or other ligands: a tool to study the unique hinge-region plasticity of the enzyme without packing bias.
    Klopffleisch K; Issinger OG; Niefind K
    Acta Crystallogr D Biol Crystallogr; 2012 Aug; 68(Pt 8):883-92. PubMed ID: 22868753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic activity with an incomplete catalytic spine: insights from a comparative structural analysis of human CK2α and its paralogous isoform CK2α'.
    Bischoff N; Raaf J; Olsen B; Bretner M; Issinger OG; Niefind K
    Mol Cell Biochem; 2011 Oct; 356(1-2):57-65. PubMed ID: 21739153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational flexibility of human casein kinase catalytic subunit explored by metadynamics.
    Gouron A; Milet A; Jamet H
    Biophys J; 2014 Mar; 106(5):1134-41. PubMed ID: 24606937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of CX-4945 binding to human protein kinase CK2.
    Ferguson AD; Sheth PR; Basso AD; Paliwal S; Gray K; Fischmann TO; Le HV
    FEBS Lett; 2011 Jan; 585(1):104-10. PubMed ID: 21093442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit.
    Ermakova I; Boldyreff B; Issinger OG; Niefind K
    J Mol Biol; 2003 Jul; 330(5):925-34. PubMed ID: 12860116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the human protein kinase CK2 catalytic subunit CK2α' and interaction thermodynamics with the regulatory subunit CK2β.
    Bischoff N; Olsen B; Raaf J; Bretner M; Issinger OG; Niefind K
    J Mol Biol; 2011 Mar; 407(1):1-12. PubMed ID: 21241709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional analysis of the flexible regions of the catalytic α-subunit of protein kinase CK2.
    Papinutto E; Ranchio A; Lolli G; Pinna LA; Battistutta R
    J Struct Biol; 2012 Feb; 177(2):382-91. PubMed ID: 22186626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First inactive conformation of CK2 alpha, the catalytic subunit of protein kinase CK2.
    Raaf J; Issinger OG; Niefind K
    J Mol Biol; 2009 Mar; 386(5):1212-21. PubMed ID: 19361447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase CK2 in health and disease: Protein kinase CK2: from structures to insights.
    Niefind K; Raaf J; Issinger OG
    Cell Mol Life Sci; 2009 Jun; 66(11-12):1800-16. PubMed ID: 19387553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Plasticity of Crystalline CK2α' Leads to KN2, a Bivalent Inhibitor of Protein Kinase CK2 with Extraordinary Selectivity.
    Lindenblatt D; Applegate V; Nickelsen A; Klußmann M; Neundorf I; Götz C; Jose J; Niefind K
    J Med Chem; 2022 Jan; 65(2):1302-1312. PubMed ID: 34323071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The catalytic subunit of human protein kinase CK2 structurally deviates from its maize homologue in complex with the nucleotide competitive inhibitor emodin.
    Raaf J; Klopffleisch K; Issinger OG; Niefind K
    J Mol Biol; 2008 Mar; 377(1):1-8. PubMed ID: 18242640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.
    Sekiguchi Y; Nakaniwa T; Kinoshita T; Nakanishi I; Kitaura K; Hirasawa A; Tsujimoto G; Tada T
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2920-3. PubMed ID: 19414254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposed Allosteric Inhibitors Bind to the ATP Site of CK2α.
    Brear P; Ball D; Stott K; D'Arcy S; Hyvönen M
    J Med Chem; 2020 Nov; 63(21):12786-12798. PubMed ID: 33119282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase CK2 in health and disease: Structural bases of protein kinase CK2 inhibition.
    Battistutta R
    Cell Mol Life Sci; 2009 Jun; 66(11-12):1868-89. PubMed ID: 19387547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.
    Bollacke A; Nienberg C; Borgne ML; Jose J
    J Pharm Biomed Anal; 2016 Mar; 121():253-260. PubMed ID: 26786382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and Mechanistic Basis of the Inhibitory Potency of Selected 2-Aminothiazole Compounds on Protein Kinase CK2.
    Lindenblatt D; Nickelsen A; Applegate VM; Jose J; Niefind K
    J Med Chem; 2020 Jul; 63(14):7766-7772. PubMed ID: 32589844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening.
    Li C; Zhang X; Zhang N; Zhou Y; Sun G; Zhao L; Zhong R
    Molecules; 2020 Jan; 25(1):. PubMed ID: 31935979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the Impact of Linker Flexibility and Fragment Ionization on the Design of CK2 Allosteric Inhibitors: Comparative Molecular Dynamics Simulation Studies.
    Zhou Y; Zhang N; Qi X; Tang S; Sun G; Zhao L; Zhong R; Peng Y
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29301250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.